Home › Ensemble Therapeutics And Alexion Initiate Collaboration To Discover Macrocycle Drug Candidates Targeting Patients With Severe And Ultra-Rare Disorders
 

Keywords :   


Ensemble Therapeutics And Alexion Initiate Collaboration To Discover Macrocycle Drug Candidates Targeting Patients With Severe And Ultra-Rare Disorders

2013-07-18 09:30:00| drugdiscoveryonline Home Page

Ensemble Therapeutics, a biotechnology company developing Ensemblins, a novel class of small molecule therapeutics with the potential to modulate targets typically addressed by biologics, recently announced the initiation of a drug discovery collaboration with a subsidiary of Alexion Pharmaceuticals, Inc., the global biopharmaceutical company focused on developing and commercializing life-transforming therapies for patients with life-threatening, ultra-rare disorders

Tags: drug discover patients collaboration

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Farm Progress America, July 3, 2024
03.07Farm Progress America, July 3, 2024
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
03.07Hurricane Beryl Public Advisory Number 19
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Forecast Advisory Number 19
More »